Argenica Therapeutics Limited (ASX:AGN)

Argenica Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	15.08	15.91	9.29	8.91	7.14	0.34
Short-Term Investments	-	-	0.05	-	-	-
Cash & Short-Term Investments	15.08	15.91	9.34	8.91	7.14	0.34
Cash Growth	78.88%	70.39%	4.76%	24.78%	1989.04%	-
Other Receivables	0.26	0.37	0.15	0.07	0.08	0.03
Receivables	0.26	0.37	0.15	0.07	0.08	0.03
Prepaid Expenses	0.07	0.09	0.05	0.06	0.05	-
Other Current Assets	-	-	-	-	-	0
Total Current Assets	15.41	16.38	9.54	9.04	7.27	0.38
Other Intangible Assets	0	0	0	0	0	0
Total Assets	15.41	16.38	9.54	9.04	7.27	0.38
Accounts Payable	1.43	1.4	1.14	0.67	0.37	0.35
Accrued Expenses	0.05	0.3	0.05	0.05	0.04	0.01
Current Unearned Revenue	0.74	0.7	0.66	-	-	-
Other Current Liabilities	-	0.02	0.02	0.02	0.01	-
Total Current Liabilities	2.22	2.43	1.87	0.74	0.43	0.36
Total Liabilities	2.22	2.43	1.87	0.74	0.43	0.36
Common Stock	29.15	28.43	16.62	13.07	8.05	0.4
Retained Earnings	-16.87	-15.69	-10.32	-5.5	-1.41	-0.38
Comprehensive Income & Other	0.92	1.21	1.37	0.75	0.21	-
Shareholders' Equity	13.19	13.95	7.67	8.31	6.85	0.02
Total Liabilities & Equity	15.41	16.38	9.54	9.04	7.27	0.38
Net Cash (Debt)	15.08	15.91	9.34	8.91	7.14	0.34
Net Cash Growth	78.88%	70.39%	4.76%	24.78%	1989.04%	-
Net Cash Per Share	0.13	0.15	0.13	0.12	0.20	0.02
Filing Date Shares Outstanding	128.09	127.13	99.15	86.92	73.17	26
Total Common Shares Outstanding	128.09	123.7	98.35	86.92	73.17	26
Working Capital	13.19	13.95	7.67	8.31	6.85	0.02
Book Value Per Share	0.10	0.11	0.08	0.10	0.09	0.00
Tangible Book Value	13.19	13.95	7.67	8.31	6.85	0.02
Tangible Book Value Per Share	0.10	0.11	0.08	0.10	0.09	0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.